InvestorsObserver
×
News Home

Is DBV Technologies SA - ADR (DBVT) a Leader in the Biotechnology Industry?

Thursday, June 30, 2022 12:15 PM | InvestorsObserver Analysts

Mentioned in this article

Is DBV Technologies SA - ADR (DBVT) a Leader in the Biotechnology Industry?

DBV Technologies SA - ADR (DBVT) is near the top in its industry group according to InvestorsObserver. DBVT gets an overall rating of 82. That means it scores higher than 82 percent of stocks. DBV Technologies SA - ADR gets a 97 rank in the Biotechnology industry. Biotechnology is number 34 out of 148 industries.

Overall Score - 82
DBVT has an Overall Score of 82. Find out what this means to you and get the rest of the rankings on DBVT!

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. InvestorsObserver makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts.
This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With DBV Technologies SA - ADR Stock Today?

DBV Technologies SA - ADR (DBVT) stock is trading at $2.32 as of 11:44 AM on Thursday, Jun 30, a drop of -$0.10, or -4.05% from the previous closing price of $2.42. The stock has traded between $2.19 and $2.32 so far today. Volume today is less active than usual. So far 91,827 shares have traded compared to average volume of 1,113,285 shares. Click Here to get the full Stock Report for DBV Technologies SA - ADR stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App